SEC Comment Letter 0000000000-24-000751 to Microbot Medical Inc. (MBOT)
Microbot Medical Inc.
Date: Jan. 19, 2024 · CIK: 0000883975 · Accession: 0000000000-24-000751
AI Filing Summary & Sentiment
File numbers found in text: 333-276487
Letter
United States securities and exchange commission logo January 19, 2024 Harel Gadot President, Chief Executive Officer and Chairman Microbot Medical Inc. 288 Grove Street, Suite 388 Braintree, MA 02184 Re:Microbot Medical Inc. Registration Statement on Form S-1 Filed January 12, 2024 File No. 333-276487 Dear Harel Gadot: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Stephen E. Fox, Esq.
Show Raw Text
United States securities and exchange commission logo
January 19, 2024
Harel Gadot
President, Chief Executive Officer and Chairman
Microbot Medical Inc.
288 Grove Street, Suite 388
Braintree, MA 02184
Re:Microbot Medical Inc.
Registration Statement on Form S-1
Filed January 12, 2024
File No. 333-276487
Dear Harel Gadot:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Stephen E. Fox, Esq.